Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma

Xu, YZ; Kong, W; Cao, M; Wang, JY; Wang, ZY; Zheng, L; Wu, XY; Cheng, RR; He, W; Yang, B; Dong, BJ; Pan, JH; Chen, YH; Huang, JW; Jiang, C; Zhai, W; Li, FZ; Chen, RH; Zhou, X; Wu, GY; Geng, XC; Chen, JS; An, HM; Yuan, YC; Xu, TY; Chen, DN; Lin, DQ; Xu, LY; Huang, KB; Peng, L; Yu, YF; Tai, SC; Qi, HG; Luo, K; Kang, XA; Wang, H; Huang, YR; Zhang, J; Xue, W

Huang, YR; Zhang, J; Xue, W (通讯作者)，Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Urol, 160 Pujian Rd, Shanghai 200127, Peoples R China.

EUROPEAN UROLOGY, 2023; 83 (2): 163

Abstract

Background: FH-deficient renal cell carcinoma (RCC) is a rare and exceptionally aggres-sive RCC subtype. There is currently limited understanding of t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索